The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizationsDonald S. Silverberg, Adrian Iaina, Doron Schwartz et al.|Journal of the American College of Cardiology|2000Cited by 729
The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled studyDonald S. Silverberg, Adrian Iaina, Dov Wexler et al.|Journal of the American College of Cardiology|2001Cited by 645
The association between congestive heart failure and chronic renal diseaseDonald S. Silverberg, Adrian Iaina, Dov Wexler et al.|Current Opinion in Nephrology & Hypertension|2004Cited by 174
The Importance of Anemia and its Correction in the Management of Severe Congestive Heart FailuresDonald S. Silverberg, Adrian Iaina, Dov Wexler|European Journal of Heart Failure|2002Cited by 172
The Interaction Between Heart Failure and Other Heart Diseases, Renal Failure, and AnemiaDonald S. Silverberg, Doron Schwartz, Dov Wexler et al.|Seminars in Nephrology|2006Cited by 128